0001209191-20-024291.txt : 20200413
0001209191-20-024291.hdr.sgml : 20200413
20200413210617
ACCESSION NUMBER: 0001209191-20-024291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200409
FILED AS OF DATE: 20200413
DATE AS OF CHANGE: 20200413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BASKETT FOREST
CENTRAL INDEX KEY: 0001277631
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38129
FILM NUMBER: 20789827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mersana Therapeutics, Inc.
CENTRAL INDEX KEY: 0001442836
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-498-0020
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MERSANA THERAPEUTICS INC
DATE OF NAME CHANGE: 20080813
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-09
0
0001442836
Mersana Therapeutics, Inc.
MRSN
0001277631
BASKETT FOREST
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Common Stock
2020-04-09
4
J
0
4000000
0.00
D
7959520
I
See Note 2
Common Stock
2020-04-09
4
J
0
40000
0.00
A
40000
I
See Note 4
Common Stock
2020-04-09
4
J
0
40000
0.00
D
0
I
See Note 4
Common Stock
2020-04-09
4
J
0
20000
0.00
A
20000
I
See Note 7
Common Stock
2020-04-09
4
J
0
20000
0.00
D
0
I
See Note 7
Common Stock
2020-04-09
4
J
0
77
0.00
A
77
I
See Note 10
Common Stock
2020-04-09
4
J
0
12054
0.00
A
12131
I
See Note 10
Common Stock
2020-04-09
4
J
0
2197
0.00
A
2197
I
See Note 13
Common Stock
2020-04-09
4
J
0
8783
0.00
A
20914
I
See Note 10
Common Stock
2020-04-09
4
J
0
993
0.00
A
3190
I
See Note 13
Common Stock
2020-04-13
4
S
0
20914
8.5003
D
0
I
See Note 10
New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 4,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on April 9, 2020.
The Reporting Person is a director of NEA 14 GP, LTD ("NEA 14 LTD"), which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of NEA 14, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
NEA Partners 14 received 40,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA Partners 14, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 14 shares in which the Reporting Person has no pecuniary interest.
NEA Partners 14 made a pro rata distribution for no consideration of an aggregate of 40,000 shares of Common Stock of the Issuer to its limited partners on April 9, 2020.
NEA 14 Manager Fund, L.P. ("NEA 14 Manager Fund") received 20,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA 14 Manager Fund. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA 14 Manager Fund in which the Reporting Person has no pecuniary interest.
NEA 14 Manager Fund made a pro rata distribution for no consideration of an aggregate of 20,000 shares of Common Stock of the Issuer to its limited partners on April 9, 2020.
New Enterprise Associates, LLC ("NEA LLC") received 77 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
The Reporting Person is a member of the Board of Directors of NEA LLC, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA LLC in which the Reporting Person has no pecuniary interest.
NEA LLC received 12,054 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on April 9, 2020.
The Baskett-McKay Family Trust dtd 3/12/14 (the "Baskett Trust") received 2,197 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on April 9, 2020.
The securities are held directly by the Baskett Trust. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, of such portion of the shares of Common Stock of the Issuer held by the Baskett Trust in which the Reporting Person has no pecuniary interest.
NEA LLC received 8,783 shares of Common Stock of the Issuer in the distribution by NEA 14 Manager Fund on April 9, 2020.
The Baskett Trust received 993 shares of Common Stock of the Issuer in the distribution by NEA 14 Manager Fund on April 9, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.44 to $8.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (16) to this Form 4.
/s/ Sasha Keough, Attorney-in-Fact
2020-04-13